Replimune Group
Stock Forecast, Prediction & Price Target
Replimune Group (REPL) stock Price Target by analysts
$19
Potential upside: 261.21%
Replimune Group price prediction
What is Replimune Group stock analysts` prediction?
Replimune Group stock forecast: Based on 1 Wall Street analysts` predicted price targets for Replimune Group in the last 3 months, the avarage price target is $19, with a high forecast of $NaN. The average price target represents a 261.21% change from the last price of $5.26.
Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.
Replimune Group stock Price Target by analysts
Full breakdown of analysts given Replimune Group price targets
| Analyst name & company | Analyst win rate | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|---|
Roger Song Jefferies | 0% 0/1 | 10 months ago | $19 261.21% upside | $14.48 | StreetInsider | Previous targets (0) |
Robert Burns H.C. Wainwright | 0% 0/1 | over 1 year ago | $17 223.19% upside | $7.11 | TheFly | Previous targets (0) |
Peter Lawson Barclays | 0% 0/1 | over 1 year ago | $13 147.14% upside | $5.37 | StreetInsider | Previous targets (0) |
Evan Seigerman BMO Capital | 0% 0/1 | over 1 year ago | $14 166.15% upside | $6.85 | StreetInsider | Previous targets (0) |
Unknown BMO Capital | N/A | almost 3 years ago | $70 1230.79% upside | $25 | Benzinga | N/A |
Unknown Leerink Partners | N/A | almost 3 years ago | $34 546.38% upside | $23.09 | Benzinga | N/A |
Unknown Leerink Partners | N/A | almost 3 years ago | $30 470.34% upside | $17.27 | Benzinga | N/A |
Unknown Piper Sandler | N/A | about 3 years ago | $43 717.49% upside | $20.62 | Benzinga | N/A |
Unknown Leerink Partners | N/A | about 3 years ago | $37 603.42% upside | $20.37 | Benzinga | N/A |
Unknown Leerink Partners | N/A | over 3 years ago | $48 812.54% upside | $14.38 | Benzinga | N/A |
Replimune Group Financial Estimates
Replimune Group Revenue Estimates
Replimune Group EBITDA Estimates
Replimune Group Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 3/31/2022 | 3/31/2023 | 3/31/2024 | 3/31/2026 | 3/31/2027 | 3/31/2028 | 3/31/2029 |
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $17.82M Low: $8.26M High: $31.59M avg. 0% | Avg: $121.36M Low: $59.15M High: $218.38M avg. 580.94% | Avg: $365.96M Low: $178.39M High: $658.54M avg. 201.54% | Avg: $552.79M Low: $269.46M High: $994.75M avg. 51.05% |
Net Income
% change YoY
| $-118.03M N/A | $-174.28M -47.65% | $-215.79M -23.81% | Avg: $-250.24M Low: $-208.36M High: $-161.09M avg. -15.96% | Avg: $-148.14M Low: $-107.84M High: $-95.86M avg. 40.79% | Avg: $-48.59M Low: $-99.10M High: $-16.21M avg. 67.19% | Avg: $27.07M Low: $9.03M High: $55.20M avg. 155.70% |
EBITDA
% change YoY
| $-114.05M N/A | $-170.30M -49.31% | $-230.19M -35.16% | Avg: $0 Low: $0 High: $0 avg. 100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
EPS
% change YoY
| -$2.26 N/A | -$2.99 -32.30% | -$3.24 -8.36% | Avg: -$2.8 Low: -$3.13 High: -$2.42 avg. 13.59% | Avg: -$1.55 Low: -$1.62 High: -$1.44 avg. 44.63% | Avg: -$0.73 Low: -$1.49 High: -$0.24 avg. 52.90% | Avg: $0.41 Low: $0.14 High: $0.83 avg. 155.70% |
Operating Expenses
% change YoY
| $115.14M N/A | $174.16M 51.25% | $234.77M 34.79% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
FAQ
What is Replimune Group stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 61.93% in 2026-2029.
We have gathered data from 4 analysts. Their low estimate is -208.36M, average is -250.24M and high is -161.09M.
What is Replimune Group stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 208.38% in 2026-2029.
We have gathered data from 4 analysts. Their low revenue estimate is $8.26M, average is $17.82M and high is $31.59M.
What is Replimune Group stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 66.71% in 2026-2029.
We have gathered data from 4 analysts. Their low earnings per share estimate is -$3.13, average is -$2.8 and high is $-2.42.
What is the best performing analyst?
In the last twelve months 1 analysts have been covering Replimune Group stock. The most successful analyst is Roger Song.